Roots Analysis is pleased to announce the publication of its recent study, titled, “Patient Recruitment and Retention Services Market (3rd Edition), 2022 – 2035.”
The report features an extensive study of companies engaged in offering patient recruitment services and patient retention services. The study features an in-depth analysis of the key drivers and trends related to this domain. Amongst other elements, the report includes:
- A general overview of the clinical trials, patient recruitment process, patient recruitment associated services as well as the patient retention strategies employed to prevent drop-out of enrolled individuals from clinical trials.
- A brief information on the various types of patient outreach methods used by contract service providers in this domain, to identify and enroll patients in clinical trials.
- A detailed assessment of the overall landscape of patient recruitment companies and patient retention companies offering these services.
- A detailed competitiveness analysis of patient recruitment and retention service providers, segregated into three peer groups based on company size (small, mid-sized, and large and very large).
- Elaborate profiles of prominent players offering patient recruitment and retention service, based in North America, Europe and Asia Pacific.
- An analysis of the partnerships that have been inked by stakeholders engaged in this domain, from 2013-2022.
- A review of the emerging trends in the patient recruitment industry, including the use of social media, mobile technologies, electronic health records (EHR), real-world evidence (RWE) and artificial intelligence.
- A detailed discussion on the key growth opportunities in the field of patient recruitment and retention that are likely to impact the evolution of the market over the coming years.
- A case study on regulatory landscape of patient recruitment, highlighting the regulatory process, guidelines and framework.
- A brief overview of patient recruitment in clinical trials focused on personalized medicines and rare diseases.
- A detailed analysis of the annual demand for study participants, taking into account the target patient population in ongoing and planned clinical trials, sponsored by both industry and non-industry players.
- A detailed assessment on the impact of the COVID-19 pandemic on the patient recruitment and retention services market.
- A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
- Patient Recruitment Step
- Pre-screening
- Screening
- Trial Phase
- Phase I
- Phase II
- Phase III
- Phase IV
- Therapeutic Area
- Cardiovascular Disorders
- Oncological Disorders
- Infectious Diseases
- CNS Disorders
- Respiratory Disorders
- Hematological Disorders
- Dermatological Disorders
- Ophthalmic Disorders
- Others
- Key Geographical Regions
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and North Africa
- Rest of the World
Transcripts of interviews held with the following senior level representatives of stakeholder companies:
- Susan Fitzpatrick-Napier (Founder and Director, TrialWire)
- Kate Shaw (Chief Executive Officer and Founder) and Marco Lassandro (Marketing and Communications Manager, Innovative Trials)
- Simon Klaasen (Co-founder and Managing Director, Link2Trials)
- Stefan Mayer-Eggersmann (Chief Commercial Officer, Clariness)
- Ken Shore (Chief Commercial Officer, Continuum Clinical)
- Hagit Nof (Chief Operation Officer and Business Development Officer, nRollmed)
- Paul Ivsin (Ex-Managing Director, Seeker Health)
- Kasturi Lakhe (Inside Sales Specialist, EVERSANA)
Key companies covered in the report
- BBK Worldwide
- Continuum Clinical
- IQVIA
- United BioSource (UBC)
- WCG ThreeWire
- Clariness
- Fidelis Research
- Ignite Data
- Innovative Trials
- Orphan Reach
- 3H Medi Solution
- Buzzreach
- Current Medical Information Center (CMIC)
- nRollmed
- Trialfacts
To view more details on this report, click on the link:
News article
Global Cell Free Expression Market
Learn from experts: do you know about these emerging industry trends? mRNA Therapeutics and mRNA Vaccines Industry: Current Scenario and Future Trends |
4D Bioprinting Market: Key Trends
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms
Contact:
Ben Johnson
+1 (415) 800 3415
+44 (122) 391 1091
